CVS Health Corp (CVS)

Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.

Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session.

Wegovy to become preferred GLP-1 drug on CVS Caremark's top formularies in 2025 as Novo Nordisk expands patient access initiatives.

Curious about the S&P500 stocks that are gapping on Thursday? Explore the gap up and gap down stocks in the S&P500 index during today's session.

Wall Street pushed higher in midday trading, with the S&P 500 on track for its eighth consecutive gain — its longest winning streak since November 2023. The index rose about 1% to 5,560, fully recovering the losses sustained after former President Donald Trump announced trade tariffs on April 2.

CVS Health topped Q1 estimates with $94.59 billion in revenue and raised 2025 EPS outlook to $6.00–$6.20 amid strong Medicare performance.

Get insights into the top gainers and losers in the S&P500 index of Thursday's pre-market session.

Diversified healthcare company CVS Health (NYSE:CVS) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 7% year on year to $94.59 billion. Its non-GAAP profit of $2.25 per share was 34.6% above analysts’ consensus estimates.

The company now expects full-year adjusted EPS in the range of $6.00 to $6.20, up from its previous guidance of $5.75 to $6.00.

Diversified healthcare company CVS Health (NYSE:CVS) will be announcing earnings results tomorrow morning. Here’s what to expect.

Jim Cramer is preparing investors for another action-packed week on Wall Street, packed with earnings reports from major tech players and key economic updates.

Elevance Health posts strong Q1 with premium, Medicare, and CarelonRx growth, reaffirming 2025 EPS guidance above Wall Street estimates.

UnitedHealthcare Group is the best house in a rough neighborhood as its still a very profitable vertically integrated healthcare company, not just an insurer.

Healthcare sector sees volatility due to UnitedHealth's earnings disappointment, but ETFs like XLV, IHE, and XPH still show resilience and pockets of strength.

Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

CVS, Humana and Elevance shares are moving lower on Thursday after UnitedHealth reported earnings prior to the market opening.

Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top S&P500 gainers and losers in today's pre-market session.

Health insurance stocks are outperforming the benchmark indices in 2025, as these two tariff-free and recession-resistant carriers are up 16% and 54%.

Walgreens stock might be a good name to consider in the coming months, especially as new developments might boost a takeover bid.